Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Solid Tumors × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Urinary Bladder Neoplasms 9 Pancreatic Neoplasms 6 Carcinoma, Merkel Cell 5 Ovarian Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Recurrence 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Cancer Resectable 1 Non-Muscle Invasive Bladder Neoplasms 1 Nasopharyngeal Neoplasms 1 Multiple Myeloma 1 Microsatellite Instability 1 Metastatic Urothelial Cell Cancer 1 Metastatic Castration-resistant Prostate Cancer 1

Interventions

Carboplatin 3 Docetaxel 2 Cisplatin 2 BMS-753493 2 zimberelimab 1 tislelizumab 1 tesetaxel 1 spartalizumab 1 pembrolizumab 1 olaparib 1 liposomal doxorubicin 1 linifanib 1 lenvatinib 1 ixabepilone 1 durvalumab 1 avelumab 1 avdoralimab 1 adavosertib 1 TAS-119 1 Rifampin 1 Nivolumab 1 N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 1 Maximum Tolerated Dose 1 Linoleic Acids, Conjugated 1 Lapatinib 1 Itraconazole 1 Irinotecan 1 Ipilimumab 1 Injections 1 Ifosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02994953 2024-09-20

COMBO

EMD Serono

Phase 1 Terminated

52 enrolled 34 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡